Cortrosyn
PreclinicalSmall molecule
Cortrosyn is one of 5 small molecule programs targeting Obese. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Obese
#DrugCompanyPhaseTrials
1Mounjaro
Eli LillyPhase 2
Ozempic
Novo NordiskPhase 2
HRS-5817
FFujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
Urine Analysis
OOhio State University
Preclinical
Cortrosyn
UUniversity of Virginia
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Cortrosyn. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Virginia